Making the paper: Jay Keasling.

The article describes how Jay Keasling, a synthetic chemist at the University of California, Berkeley, and his team have engineered yeast cells to produce an important precursor for a drug to treat malaria. Keasling collaborated with Amyris Biotechnologies and non-profit drug company Institute for OneWorld Health to try to complete the synthesis of artemisinin. The research was funded by the Bill & Melinda Gates Foundation.